Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Apr;21(4):459–462. doi: 10.1111/j.1365-2125.1986.tb05223.x

Human gastrointestinal absorption of acyclovir from tablet duodenal infusion and sipped solution.

L D Lewis, A S Fowle, S B Bittiner, A Bye, P E Isaacs
PMCID: PMC1400928  PMID: 3707815

Abstract

On two occasions at least 1 week apart, nine healthy male volunteers were administered in random order either 2 X 200 mg (1.8 mmol) acyclovir tablets or 400 mg of acyclovir in 500 ml of 5% dextrose solution which was infused at constant rate into the duodenum over 4 h. Six of the subjects subsequently sipped the same solution at the rate of 10.4 ml in each 5 min period for 4 h. Blood and urine were sampled over 24 h for each mode of administration. Acyclovir was assayed by radioimmunoassay. Mean areas under the plasma concentration-time curves (AUCs) +/- s.d. for tablet (T), intraduodenal infusion (I) and sipping (S) were, respectively: T = 14.7 +/- 5.1; I = 24.6 +/- 5.1; S = 28.4 +/- 9.5 (n = 6) mumol l-1 h. AUCs for I and S were significantly greater than that for T (2P less than 0.05). Mean apparent maximum plasma concentrations (Cmax) +/- s.d. were T = 3.8 +/- 1.5; I = 4.8 +/- 0.9; S = 5.1 +/- 1.5 mumol l-1. This trend to higher values for I and S was not significant. Mean apparent plasma disappearance half-lives (t1/2) +/- s.d. were respectively T = 2.3 +/- 0.4; I = 2.7 +/- 0.5; S = 3.0 +/- 0.2 h, I being significantly greater than T (2P less than 0.05), as was S greater than T (2P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Llewellyn-Jones D., Abraham S. F. Quetelet index in diagnosis of anorexia nervosa. Br Med J (Clin Res Ed) 1984 Jun 16;288(6433):1800–1800. doi: 10.1136/bmj.288.6433.1800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Rogers H. J., Fowle A. S. The clinical pharmacology of acyclovir. J Clin Hosp Pharm. 1983 Jun;8(2):89–102. doi: 10.1111/j.1365-2710.1983.tb01038.x. [DOI] [PubMed] [Google Scholar]
  3. Schaeffer H. J., Beauchamp L., de Miranda P., Elion G. B., Bauer D. J., Collins P. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature. 1978 Apr 13;272(5654):583–585. doi: 10.1038/272583a0. [DOI] [PubMed] [Google Scholar]
  4. Sedman A. J., Wagner J. G. CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci. 1976 Jul;65(7):1006–1010. doi: 10.1002/jps.2600650713. [DOI] [PubMed] [Google Scholar]
  5. Selby P., Powles R. L., Blake S., Stolle K., Mbidde E. K., McElwain T. J., Hickmott E., Whiteman P. D. Amino (hydroxyethoxymethyl) purine: a new well-absorbed prodrug of acyclovir. Lancet. 1984 Dec 22;2(8417-8418):1428–1430. doi: 10.1016/s0140-6736(84)91624-6. [DOI] [PubMed] [Google Scholar]
  6. de Miranda P., Blum M. R. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother. 1983 Sep;12 (Suppl B):29–37. doi: 10.1093/jac/12.suppl_b.29. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES